Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 0.78 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.78 |
| ▸ | PTGES | O14684 | 3/20 | 0.77 |
| ▸ | TOP2A | P11388 | 1/20 | 0.77 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.64 |
| ▸ | BID | P55957 | 3/20 | 0.60 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.60 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.60 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.60 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.60 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.60 |
| ▸ | PPARG | P37231 | 1/20 | 0.60 |
| ▸ | PPARA | Q07869 | 1/20 | 0.60 |
| ▸ | EP300 | Q09472 | 1/20 | 0.60 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.60 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.60 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.60 |
| ▸ | MMP2 | P08253 | 2/20 | 0.52 |
| ▸ | F7 | P08709 | 2/20 | 0.52 |
| ▸ | F3 | P13726 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9909323 | 1.00 | PTPN1 (0.78) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL28206687 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL29647786 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL2557659 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL34463357 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL24511794 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL29635011 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL34463305 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL26725572 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL30261073 | 0.95 | PTPN1 (0.81) | PTPN1PTPN11PTGESTOP2APTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680720-A1 | OPTIMIZED PRODUCTION OF BRANCH POINT COMPOUNDS AND DERIVATIVES USING ALTERNATIVE ISOPENTENYL DIPHOSPHATE-SUPPLYING PATHWAYS | EvodiaBio ApS (DK) | 2026-01-21 | — | — | EP | claimed |
| US-12529077-B2 | Production of geranyl diphosphate-derived compounds | Københavns Universitet (DK) | 2026-01-20 | — | — | US | claimed |
| US-12460185-B2 | Optimized cannabinoid synthase polypeptides | DEMETRIX, INC. (US) | 2025-11-04 | — | — | US | claimed |
| US-20250122539-A1 | LARGE SCALE PRODUCTION OF DIVARIN, DIVARINIC ACID AND OTHER ALKYL RESORCINOLS BY FERMENTATION | LYGOS INC (US) | 2025-04-17 | — | — | US | claimed |
| CN-119793258-A | Homogenizing and emulsifying process of green tea polyphenol essence | 上海约翰杰夫化妆品有限公司 | 2025-04-11 | — | — | CN | claimed |
| US-12215327-B2 | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-02-04 | — | — | US | claimed |
| CN-119367242-A | Relaxing anti-wrinkle moisturizing emulsion and preparation method thereof | 广州市华麦生物科技有限公司 | 2025-01-28 | — | — | CN | claimed |
| US-12180516-B2 | Biosynthetic platform for the production of cannabinoids and other prenylated compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-12-31 | — | — | US | claimed |
| WO-2024189183-A1 | OPTIMIZED PRODUCTION OF BRANCH POINT COMPOUNDS AND DERIVATIVES USING ALTERNATIVE ISOPENTENYL DIPHOSPHATE-SUPPLYING PATHWAYS | EVODIABIO APS (DK) | 2024-09-19 | — | — | WO | claimed |
| WO-2024098353-A1 | RECOMBINANT SACCHAROMYCES CEREVISIAE FOR PRODUCING CANNABIGEROLIC ACID, CONSTRUCTION METHOD THEREFOR, AND USE THEREOF | 中国科学院深圳先进技术研究院 | 2024-05-16 | — | — | WO | claimed |
| US-20220228130-A1 | OPTIMIZED CANNABINOID SYNTHASE POLYPEPTIDES | DEMETRIX, INC. | 2022-07-21 | — | — | US | claimed |
| EP-4025705-A2 | PRENYLTRANSFERASE VARIANTS AND METHODS FOR PRODUCTION OF PRENYLATED AROMATIC COMPOUNDS | Genomatica, Inc. (US) | 2022-07-13 | — | — | EP | claimed |
| CN-114729386-A | Enzymes for cannabinoid synthesis and methods of making and using same | 杭州恩和生物科技有限公司 | 2022-07-08 | — | — | CN | claimed |
| US-20220213519-A1 | Neurotransmitters and Methods of Making the Same | Purissima, Inc. (US) | 2022-07-07 | — | — | US | claimed |
| US-20220186270-A1 | Neurotransmitters and Methods of Making the Same | Purissima, Inc. (US) | 2022-06-16 | — | — | US | claimed |
| US-20220170055-A1 | OLIVETOLIC ACID CYCLASE VARIANTS WITH IMPROVED ACTIVITY FOR USE IN PRODUCTION OF PHYTOCANNABINOIDS | HYASYNTH BIOLOGICALS INC. (CA) | 2022-06-02 | — | — | US | claimed |
| US-20220170056-A1 | COMPOSITIONS AND METHODS FOR BIOSYNTHESIS OF TERPENOIDS OR CANNABINOIDS IN A HETEROLOGOUS SYSTEM | INMED PHARMACEUTICALS INC. (CA) | 2022-06-02 | — | — | US | claimed |
| WO-2022104460-A1 | OLIVETOLIC ACID CYCLASE VARIANTS WITH IMPROVED ACTIVITY FOR USE IN PRODUCTION OF PHYTOCANNABINOIDS | HYASYNTH BIOLOGICALS INC. (CA) | 2022-05-27 | — | — | WO | claimed |
| US-11293041-B2 | Neurotransmitters and methods of making the same | Purissima, Inc. (US) | 2022-04-05 | — | — | US | claimed |
| CN-111116371-B | Novel moss fen-flavor compound 4-methoxy ethyl olivetolate, preparation method and application thereof | 华宝香精股份有限公司 | 2022-02-01 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529077-B2 | Production of geranyl diphosphate-derived compounds | GGPS1, OGA, GBA3 | PTPN1 3536/4885PTPN11 3077/4885PTGES 736/4885 |
| US-12215327-B2 | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | CNR2, CNR1, FAAH | PTPN1 3635/4885PTPN11 3476/4885PTGES 179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.